Patient Blood Management Guidelines: Module 2

Perioperative

Appendix D - Process report

D1 Development process

A review by the NBA of the 2001 Clinical Practice Guidelines on the Use of Blood Components1 led to a decision by the NHMRC, ANZSBT and NBA to develop a series of six guidelines on patient blood management, of which this document is the second. The guidelines development process was initiated by a Steering Committee chaired by the NBA. In 2008, an EWG was formed to oversee development of the series of guidelines.

A CRG, with membership including an independent consumer advocate and representation from relevant colleges and societies, was established to develop the perioperative module, with assistance from systematic reviewers and a technical writer, and advice and mentoring from GAR consultants initially contracted by the NHMRC. Further details of the governance framework are provided in Section 1.2 and Appendix A.

D2 Research phase

Relevant clinical research questions were developed, prioritised, combined and refined by the EWG and the CRG for this guideline, and further refined through consultation among the systematic reviewer, CRG, NBA and NHMRC GAR consultants.2,4

D3 Methodology

Methods are outlined in Chapter 2, with greater detail given in the technical reports.2,4 Briefly, the clinical research questions for systematic review were structured according to PICO (‘population, intervention, comparator and outcome’ for intervention questions), PPO (‘population, predictor and outcome’ for prognostic questions) or PRO (‘population, risk factor and outcome’ for aetiology questions) criteria. Three main strategies were used to identify potentially relevant literature: electronic database searching, manual searching and use of literature recommended by expert members of the CRG.

The primary databases searched were EMBASE, Medline, the Cochrane Library Database and PreMedline. Additional searches were conducted of Cumulative Index to Nursing and Allied Health Literature and Australasian Medical Index. The electronic searches included articles published after 1966. Literature retrievals were limited by the holdings of the databases accessed. Publication cut-off points varied from 29 April 2009 to 30 June 2009, as shown in Table D.1, below. Any future searches undertaken to revise, reuse or update these searches should take 1 April 2009 as the start date, to ensure complete coverage of the date range.

Following a review of the search results by the CRG in November 2009, the terms for some searches (specific question 2 and generic question 6) were revised to ensure inclusion of patients undergoing invasive procedures and minimally invasive surgical procedures (see Table D.2, below, and Section 2.1.2 and Appendix 1 of Volume 1a of the technical report for specific patient populations and subgroups). Table D.1 shows the dates on which the revised searches were conducted. The cut-off date for these searches was 30 June 2009, to better align with previous cut-off dates.

Table D.1 Search dates and cut-off points

CONDUCTED WITH CUT-OFF UPDATED WITH CUT-OFF
Specific question 1
EMBASE.com 4/06/2009 4/06/2009 - -
Cochrane Library Database 12/06/2009 12/06/2009 - -
PreMedline 15/06/2009 15/06/2009 - -
CINAHL 11/06/2009 11/06/2009 - -
AMI 11/06/2009 11/06/2009 - -
BMJ Clinical Evidence 18/06/2009 18/06/2009 - -
Specific question 2
EMBASE.com 12/06/2009 12/06/2009 28/01/2010 30/06/2009
Cochrane Library Database 18/06/2009 18/06/2009 27/01/2010 30/06/2009
PreMedline 18/06/2009 18/06/2009 - -
CINAHL 16/06/2009 16/06/2009 21/01/2010 30/06/2009
AMI 16/06/2009 16/06/2009 - -
Specific question 3
Searches by IMS Ltd.
EMBASE.com 17/06/2009 17/06/2009 - -
Cochrane Library Database 22/06/2009 22/06/2009 - -
PreMedline 22/06/2009 22/06/2009 - -
CINAHL 19/06/2009 19/06/2009 - -
AMI 19/06/2009 19/06/2009 - -
Searches by HTA Ltd.
Intervention 1 (acute normovolemic haemodilution)
Embase SR 21/12/2009 30/06/2009 - -
Cochrane SR 22/12/2009 30/06/2009 - -
Embase RCT 3/01/2010 30/06/2009 - -
Cochrane RCT 3/01/2010 30/06/2009 - -
Interventions 2–4 (cell salvage)
EMBASE SR 22/12/2009 30/06/2009 - -
Cochrane SR 22/12/2009 30/06/2009 - -
Intervention 2 (intraoperative cell salvage)
EMBASE RCT 3/01/2010 30/06/2009 - -
Cochrane RCT 3/01/2010 30/06/2009 - -
Intervention 3 (ANH and intraoperative cell salvage)
EMBASE RCT 3/01/2010 30/06/2009 - -
Cochrane RCT 3/01/2010 30/06/2009 - -
EMBASE lower level evidence 11/02/2010 30/06/2009 - -
Intervention 4 (postoperative cell salvage)
EMBASE RCT 3/01/2010 30/06/2009 - -
Cochrane RCT 3/01/2010 30/06/2009 - -
Intervention 5 (induced hypotension)
EMBASE SR 21/12/2009 30/06/2009 - -
Cochrane SR 22/12/2009 30/06/2009 - -
EMBASE RCT 4/01/2010 30/06/2009 - -
Cochrane RCT 4/01/2010 30/06/2009 - -
Intervention 6 (prevention of hypothermia)
EMBASE SR 21/12/2009 30/06/2009 - -
Cochrane SR 22/10/2009 30/06/2009 - -
EMBASE RCT 5/01/2010 30/06/2009 - -
Cochrane RCT 5/01/2010 30/06/2009 - -
Intervention 7 (point-of-care testing)
EMBASE SR 21/12/2009 30/06/2009 - -
Cochrane SR 22/12/2009 30/06/2009 - -
EMBASE RCT 2/02/2010 30/06/2009 - -
Cochrane RCT 2/02/2010 30/06/2009 - -
EMBASE lower level evidence 8/04/2010 30/06/2009 - -
Intervention 8 (antifibrinolytics)
EMBASE SR 21/12/2009 30/06/2009 - -
Cochrane SR 22/12/2009 30/06/2009 - -
EMBASE RCT (desmopressin) 16/02/2010 30/06/2009 - -
Cochrane RCT 16/02/2010 30/06/2009 - -
EMBASE RCT (aminocaproic and tranexamic acid) 24/02/2010 30/06/2009 - -
Intervention 9 (patient positioning)
EMBASE SR 21/12/2009 30/06/2009 - -
Cochrane SR 22/12/2009 30/06/2009 - -
EMBASE RCT 3/01/2009 30/06/2009 - -
Cochrane RCT 3/01/2009 30/06/2009 - -
Intervention 10 (autologous transfusion)
EMBASE SR 22/12/2009 30/06/2009 - -
Cochrane SR 22/12/2009 30/06/2009 - -
EMBASE RCT 3/01/2010 30/06/2009 - -
Cochrane RCT 3/01/2010 30/06/2009 - -
Quality of life search (all interventions)
EMBASE lower level evidence 14/02/2010 30/06/2009 - -
Generic question 1
EMBASE.com 29/04/2009 29/04/2009 - -
Cochrane Library Database 14/05/2009 14/05/2009 - -
PreMedline 14/05/2009 14/05/2009 - -
CINAHL 14/05/2009 14/05/2009 - -
AMI 26/06/2009 26/06/2009 - -
Generic question 2
EMBASE.com 13/05/2009 13/05/2009 - -
Cochrane Library Database 13/05/2009 13/05/2009 - -
PreMedline 18/05/2009 18/05/2009 - -
CINAHL 28/05/2009 28/05/2009 - -
AMI 11/06/2009 11/06/2009 - -
Generic question 3
EMBASE.com 27/05/2009 27/05/2009 - -
Cochrane Library Database 21/05/2009 21/05/2009 - -
PreMedline 28/05/2009 28/05/2009 - -
CINAHL 14/05/2009 14/05/2009 - -
AMI 14/05/2009 14/05/2009/td> - -
Generic question 4
EMBASE.com 24/06/2009 24/06/2009 - -
Cochrane Library Database 24/06/2009 24/06/2009 - -
PreMedline 24/06/2009 24/06/2009 - -
CINAHL 23/06/2009 23/06/2009s - -
Generic question 5
EMBASE.com 25/06/2009 25/06/2009 - -
Cochrane Library Database 25/06/2009 25/06/2009 - -
PreMedline 25/06/2009 25/06/2009 - -
CINAHL 26/06/2009 26/06/2009 - -
AMI 30/06/2009 30/06/2009 - -
Generic question 6
EMBASE.com 28/06/2009 28/06/2009 4/01/2010 30/06/2009
Cochrane Library Database 28/06/2009 28/06/2009 4/01/2010 30/06/2009
PreMedline 28/06/2009 28/06/2009 - -
CINAHL 30/06/2009 30/06/2009 6/01/2010 30/06/2009
AMI 30/06/2009 30/06/2009 6/01/2010 30/06/2009

AMI, Australasian Medical Index; CINAHL, Cumulative Index to Nursing and Allied Health Literature; EMBASE, Excerpta Medica Database; RCT, randomised controlled trial; SR, systematic review

Table D.2 Populations,subgroups and stratification criteria

QUESTION POPULATION SUBGROUPS STRATIFIED BY
1 All patients scheduled for surgery – elective and emergency patients
  • Anaemic vs. non-anaemic
2 All surgical and invasive procedures
  • Obstetrics patients
  • Patients scheduled for neurosurgery and ophthalmic surgery
  • According to indication for intervention (prosthetic valve, VTE, AF, coronary stent)
3 All surgical patients (elective, emergency, obstetrics and paediatric/neonates)
  • Stratified by surgical type (e.g. cardiothoracic, neurosurgery or trauma)
  • Massive transfusion
4 All patients
  • Perioperative
  • Trauma
  • Shock
  • Massive transfusion
  • Cardiothoracic
  • Surgical
  • Aetiology of anaemia if present (iron deficiency vs. other)
  • Demographics (age/sex)
5 All patients, with or without defined anaemia (however defined)
  • Perioperative
  • Trauma
  • Shock
  • Massive transfusion
  • Cardiothoracic
  • Surgical
  • Anaemia status according to Hb level
6 All patients with anaemia
  • Perioperative
  • Trauma
  • Shock
  • Massive transfusion
  • Cardiothoracic
  • Surgical
7 All patients, with and without anaemia
  • Perioperative
  • Trauma
  • Shock
  • Massive transfusion
  • Cardiothoracic
  • Surgical
8 All patients, with and without anaemia
  • Perioperative
  • Trauma
  • Shock
  • Massive transfusion
  • Cardiothoracic
  • Surgical
9 All adult (medical, surgical or obstetric), neonatal and paediatric patients eligible for transfusion, with and without anaemia
  • Perioperative
  • Trauma
  • Shock
  • Massive transfusion
  • Cardiothoracic
  • Surgical
  • Non-surgical invasive procedures and minimally invasive surgical procedures

Inclusion criteria were determined from the PICO, PPO or PRO criteria that formed the basis of the systematically reviewed research questions. Non-English publications were excluded. Studies that were eligible for inclusion were evaluated according to NHMRC levels of evidence hierarchy, dimensions of evidence and quality assessment criteria.297,298 An NHMRC evidence statement form was completed for each systematically reviewed research question. Where there was sufficient evidence to formulate a recommendation, NHMRC grading criteria were applied to indicate the strength of the body of evidence underpinning the recommendation.297 Where it was not possible to develop evidence-based recommendations because no evidence was identified, or where additional information was required to supplement recommendations and guide clinical practice, the CRG developed practice points through a consensus-based process.

D4 Public consultation

Public consultation was conducted for eight weeks, from 7 February 2011, during which time the draft module was available on the NBA website. Notification was posted in The Australian national newspaper, and the NBA invited a range of stakeholders, committees, working groups and interested people to provide submissions.

Twenty-five submissions were received. The CRG met on 9–10 May and 12–13 July to consider all responses to the public consultation submissions and, where necessary, revise this module in accordance with the submissions. Many changes were made to the module, to address comments and concerns raised in submissions, and to improve clarity.

D5 Finalising the guidelines

The final drafts of the module and technical reports were reviewed by a guidelines development expert (formerly a GAR consultant) to assess compliance with NHMRC requirements for externally developed guidelines. The module was then reviewed by an AGREE II expert to assess it against international quality standards. The module and accompanying documents were then sent to the NHMRC for methodological and independent peer review on 4 August 2011.

The module was further refined in response to the reviewer’s recommendations.

Approval from the NHMRC was received on 15 November 2011.